Context Therapeutics: Latest News, Top Stories & Analysis - Page 3 of 3

Context Therapeutics to Showcase CT-95 Data at AACR 2025

March 28, 2025March 27, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced that new research on its clinical asset, CT-95, will be unveiled at the American Association for Cancer Research (AACR) Annual Meeting …

Regional

Context Therapeutics Reports 2024 Results and Outlines Clinical Advancements

March 22, 2025March 21, 2025 - by Timothy Alexander

PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has reported its financial results for the year ending December 31, 2024, while highlighting advancements in its clinical pipeline.